Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Medscape21h
Sciatic Nerve Injury Following Intramuscular Injection: A Case Report and Review of the Literature
When giving gluteal injections, it is safest to use the ... Medical treatments including administration of vitamins and alphachymotrypsine have been tried with varying results, depending on ...